Opicapone's onset and stabilisation of treatment effects in Parkinson's disease patients with motor fluctuations

被引：0
|
作者：
Lees, A. [1 ]
Ferreira, J. [2 ]
Reichmann, H. [3 ]
Tolosa, E. [4 ]
Santos, A. [5 ]
Oliveira, C. [5 ]
Oliveira, I. [5 ]
Lopes, N. [5 ]
Rocha, J. F. [5 ]
Soares-Da-Silva, P. [5 ]
机构：
[1] UCL, London, England
[2] Fac Med, Lisbon, Portugal
[3] Fac Med, Dresden, Germany
[4] Parkinson Dis Res IDIBAPS, Barcelona, Spain
[5] Coronado S Romao & S Mamede, BIAL, R&D Dept, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P31110
引用
收藏
页码：651 / 651
页数：1
相关论文
共 50 条
  • [31] Effectiveness and Safety of Opicapone in Clinical Practice in Parkinson's Disease Patients with Motor Fluctuations: the OPTIPARK Study
    Reichmann, Heinz
    Lees, Andrew
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    NEUROLOGY, 2020, 94 (15)
  • [32] BIPARK-2 Results: Efficacy of Once-Daily Opicapone for the Treatment of Patients with Parkinson's Disease and Motor Fluctuations
    Hauser, R. A.
    Lew, M.
    Lees, A. J.
    Poewe, W.
    Rascol, O.
    Olson, K.
    Farahmand, K.
    Siegert, S.
    Rocha, J. F.
    Soares-da-Silva, P.
    Liang, G. S.
    MOVEMENT DISORDERS, 2019, 34 : S2 - S3
  • [33] Effects of Once-Daily Opicapone on Duration of Overnight OFF and Time to Morning ON in Patients with Parkinson's Disease and Motor Fluctuations
    Hauser, Robert A.
    Lew, Mark F.
    Videnovic, Aleksandar
    Poewe, Werner
    Rascol, Olivier
    Ferreira, Joaquim J.
    Liang, Grace S.
    Olson, Kurt
    Farahmand, Khodayar
    Shah, Chirag
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    Klepitskaya, Olga
    ANNALS OF NEUROLOGY, 2020, 88 : S189 - S190
  • [34] Opicapone in Parkinson's patients with motor fluctuations and complications of therapy at baseline: the OPTIPARK study
    Reichmann, H.
    Lees, A.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 353 - 354
  • [35] Opicapone in Parkinson's German Patients with Motor Fluctuations: findings from the OPTIPARK Study
    Reichmann, H.
    Lees, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 354 - 355
  • [36] Entacapone in the treatment of motor fluctuations in patients with idiopathic Parkinson's disease
    Sommer, U
    Müller, A
    Herting, B
    Cormann, K
    Kohlert, F
    Reichmann, H
    NERVENARZT, 2002, 73 (08): : 761 - 764
  • [37] Safety and tolerability of opicapone in the treatment of Parkinson's disease and motor fluctuations: Analysis of pooled phase III studies
    Ferreira, J.
    Lees, A.
    Gama, H.
    Lopes, N.
    Santos, A.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S86 - S86
  • [38] Evaluation of the interaction between safinamide and opicapone in Parkinson's disease patients with fluctuations
    Garcia-Caldentey, J.
    Prats-Sedano, M. A.
    Legarda-Ramirez, I.
    Estelrich-Peyret, E.
    Vives-Pastor, B.
    Garcia, P. J.
    MOVEMENT DISORDERS, 2018, 33 : S130 - S130
  • [39] Influence of onset of motor fluctuations in the Opicapone effectiveness in Parkinson's: real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 382 - 382
  • [40] OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson's disease and Motor Fluctuations
    LeWitt, P.
    Klepitskaya, O.
    Bahroo, L.
    Liang, G.
    Rattana, S.
    Trotter, J.
    Serbin, M.
    MOVEMENT DISORDERS, 2021, 36 : S182 - S183
12345